Tom C. Karagiannis

Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents

Paul V. Licciardi, Ververis, Hiong et al. · Biologics · 2013 · 281 citations · Full text

Histone Modifications, Tumor Biology, Medicinal Chemistry +14

Clonogenic Assay: Adherent Cells

Haloom Rafehi, Christian Orlowski, George T. Georgiadis et al. · Journal of Visualized Experiments · 2011 · 219 citations · Full text

Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells

Luciano Pirola, Aneta Balcerczyk, Richard W. Tothill et al. · Genome Research · 2011 · 219 citations · Full text

Histone Modifications, Epigenetic Change, Genetics +24

Histone Deacetylase Inhibition and Dietary Short-Chain Fatty Acids

Paul V. Licciardi, Katherine Ververis, Tom C. Karagiannis · ISRN Allergy · 2011 · 122 citations · Full text

Nutrition, Dysbiosis, Immunology +20

Derivative of Bardoxolone Methyl, dh404, in an Inverse Dose-Dependent Manner Lessens Diabetes-Associated Atherosclerosis and Improves Diabetic Kidney Disease

Sih Min Tan, Arpeeta Sharma, Nada Stefanovic et al. · Diabetes · 2014 · 114 citations

Lipid Peroxidation, Immunology, Renal Inflammation +20